A while back I participated in an O/S business reform review. We reviewed various sectors prior to our deep dive and emphatically chose against healthcare.
Why?
Same reason NHS NICE came up with such an outwardly stupid response.
Too many competing special interests:
Administrators, Governments, Specialists, Surgeons, Doctors, Nurses, Drug companies, Equipment manufacturers, etc, etc.
Am sure you will find that at the root of the report was one or more of those groups who stood to lose revenue, funding, pay &/or prestige, yet had power to veto.
Wisely (imho) Avita has chosen not to flog that horse but rather concentrate on market dominance elsewhere, along with further product expansion & trials.
Cementing the US market as a clear demonstration of the enormous cost savings & patient outcomes creates a body of evidence NHS NICE special interest groups will likely be unable to counter next time.
- Forums
- ASX - By Stock
- AVH
- Ann: 15 RECELL Abstracts Accepted at 53rd Annual ABA Meeting
Ann: 15 RECELL Abstracts Accepted at 53rd Annual ABA Meeting, page-59
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.83 |
Change
0.050(1.80%) |
Mkt cap ! $199.2M |
Open | High | Low | Value | Volume |
$2.84 | $2.88 | $2.77 | $655.3K | 231.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17 | $2.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.83 | 9770 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17 | 2.820 |
1 | 17 | 2.810 |
1 | 5000 | 2.770 |
1 | 4000 | 2.750 |
2 | 11000 | 2.740 |
Price($) | Vol. | No. |
---|---|---|
2.830 | 9770 | 1 |
2.840 | 10000 | 1 |
2.850 | 1000 | 1 |
2.860 | 2000 | 1 |
2.870 | 6228 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |